B
Botamedi
Biotech & Life Sciences · Gangneung, South Korea · Founded 2001
Marine phytochemical-based therapeutics enhancing human and animal health with a focus on efficacy and safety MoreLess
Botamedi Inc., established in 2001, specializes in the development of therapeutics derived from marine phytochemicals. The company focuses on creating treatments that enhance the quality of life for both humans and animals by ensuring high efficacy and safety. Botamedi operates in the pharmaceutical and biotechnology sectors, targeting clients such as healthcare providers, research institutions, and pharmaceutical companies. The business model revolves around research collaborations, drug development, and the commercialization of marine phytochemical-based therapeutics. Revenue is generated through partnerships, licensing agreements, and the sale of proprietary therapeutic products. Botamedi's innovative approach addresses the limitations of conventional treatments by leveraging the inherent healing mechanisms of cells, thus minimizing side effects and maximizing therapeutic benefits.
Keywords: marine phytochemicals, therapeutics, drug development, efficacy, safety, biotechnology, healthcare, pharmaceutical, research collaborations, cellular health.
Company overview
Botamedi company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2001
- Headquarters
- Gangneung, South Korea
- Employees
- —
- Open positions
- None listed
- Dealroom signal
- 21.0
Valuation & funding
Botamedi funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Mar 2022 | $673M | $2.7B | DWS Group | ↗ |
Growth signals
Botamedi website traffic
Latest recorded traffic for Botamedi is 140 monthly website visits.
Comparisons
Botamedi compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Botamedi's talent
Source: Dealroom Talent Intelligence.
Investors
1 investor on Botamedi's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Botamedi has talent and traffic
In the news
Latest news about Botamedi
Recent press, funding announcements, and product moves mentioning Botamedi — open to read from the original sources.
Market sentiment
What the market is saying about Botamedi
An AI-synthesized read of the highest-engagement posts about Botamedi on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Botamedi’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.